ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751623 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751623; 2) Community: the network communities that were significantly associated with the response to NSC 751623; 3) Molecule: the relationships between components within communities and NSC 751623; 4) MDR: the compounds that were significantly associated with the NSC 751623.

NSC Compound Enrichment Correlation
NSC 679240 Null 0.0401206532535666 0.11948314
NSC 679516 Null 0.0401206532535666 0.3743049
NSC 688228 Null 0.0401206532535666 0.12463879
NSC 689626 Null 0.0401206532535666 0.15905551
NSC 694619 Null 0.0401206532535666 0.27397691
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0401206532535666 0.1251153
NSC 718781 Erlotinib hydrochloride 0.0401206532535666 -0.17743868
NSC 720134 Null 0.0401206532535666 -0.098259227
NSC 726217 Combretastatin A4-analogue 0.0401206532535666 0.29858075
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0401206532535666 -0.083808258
Total:127  Current:111    [First] [Prev] [Next] [Last]